Alpine Immune Sciences
ALPN
#3355
Rank
โ‚ฌ3.77 B
Marketcap
55,06ย โ‚ฌ
Share price
0.00%
Change (1 day)
392.06%
Change (1 year)

Revenue for Alpine Immune Sciences (ALPN)

Revenue in 2024 (TTM): โ‚ฌ51.78 Million

According to Alpine Immune Sciences's latest financial reports the company's current revenue (TTM ) is โ‚ฌ47.89 Million. In 2023 the company made a revenue of โ‚ฌ53.25 Million an increase over the revenue in the year 2022 that were of โ‚ฌ28.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alpine Immune Sciences from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ51.78 M-2.77%
2023 โ‚ฌ53.25 M90.03%
2022 โ‚ฌ28.02 M35.4%
2021 โ‚ฌ20.7 M172.75%
2020 โ‚ฌ7.58 M388.62%
2019 โ‚ฌ1.55 M152.04%
2018 โ‚ฌ0.61 M188.84%
2017 โ‚ฌ0.21 M
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA